PO Box 58871
London SE15 9BE, UK
+44 (0)7794 485294

Cedilla Publishing highly commended at 2016 BMA Medical Book Awards
We are delighted to announce that our GP pain handbook, The 10-minute consultation: persistent pain, was highly commended in the primary health care category at the 2016 BMA Medical Book Awards.

The GP judging panel commented:
"Pain management is an increasingly challenging field in general practice and this [guide] brings together a lot of useful information. It is comprehensive while concise and includes a good range from the best scientific evidence through to holistic approaches. I checked some of the sections and found them to be both accurate and up-to-date. It is a good introduction to the subject."

If you are interested in purchasing copies or translation rights, please contact Sarah Findlay on +44 (0)7794 485294 or email info@cedillapublishing.com.

News Archive

Shropshire hospitals baby deaths review cases rise to over 100
Wed, 19 Sep 2018 16:00:52 GMT
Baby and mother deaths, as well as birth injuries, are being reviewed at hospitals in Shropshire.
Making sure you get the right type of calorie
Wed, 19 Sep 2018 10:01:12 GMT
Meet the latest dietary idea being used in the battle against the bulge - the "quality" calorie.
Are drink-driving limits too high?
Wed, 19 Sep 2018 11:30:18 GMT
How are the limits on how much alcohol you can drink set?
Norgine buys rights to sell Shield?s iron deficiency therapy
Wed, 19 Sep 2018 10:54:22 +0100
Norgine has signed a deal with Shield Therapeutics allowing it to commercialise iron deficiency therapy Feraccru in Europe, Australia and New Zealand.
NICE rejects Novartis? CAR-T Kymriah for adult lymphoma
Wed, 19 Sep 2018 10:32:00 +0100
The National Institute for Health and Care Excellence has turned down NHS funding for use of Novartis’ CAR-T therapy Kymriah in adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
AI drug discovery platform gets 1m innovation boost
Wed, 19 Sep 2018 09:58:30 +0100
Innovate UK is streaming funds into a 1-million artificial intelligence (AI) research project to be delivered by the Medicines Discovery Catapult and two Cambridge-based firms with expertise in software/machine learning.